
TSHA
USDTaysha Gene Therapies Inc. Common Stock
即時價格
價格圖表
關鍵指標
市場指標
開盤
$4.290
最高
$4.540
最低
$4.000
交易量
5.02M
公司基本面
市值
1.2B
行業
生物科技
國家
United States
交易統計
平均交易量
6.14M
交易所
NMS
貨幣
USD
52週範圍
相關新聞
Raymond James Initiates Coverage On Taysha Gene Therapies with Strong Buy Rating, Announces Price Target of $13
Raymond James analyst Christopher Raymond initiates coverage on Taysha Gene Therapies with a Strong Buy rating and announces Price Target of $13.
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DALLAS, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (NASDAQ:TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies
相關股票
CPRX
Catalyst Pharmaceuticals Inc.
SLAMU
Slam Corp. Unit
FAAS
DigiAsia Corp. Ordinary Shares
QTI
QT Imaging Holdings Inc.
CNOBP
ConnectOne Bancorp Inc. Depositary Shares each representing a 1/40th interest in a share of 5.25% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
保持更新
設定價格提醒,獲取AI分析更新和即時市場新聞。